PromarkerEndo's own upcoming catalysts alongside class-defining historical readouts and upcoming primary completion dates in the same mechanism classes. Each event moves the broader thesis for PromarkerEndo. Showing past 6 months and next 12 months · 4 later hidden.
Same axes, same units. Discontinued and historical pivotal trials excluded; see Competitor Landscape below for the full set.
| Trial | Sponsor | Class | Phase / Line | Design | Primary endpoint | Dosing | Key eligibility | n |
|---|---|---|---|---|---|---|---|---|
| PromarkerEndo | Proteomics International Laboratories Ltd | Diagnostic Device | Phase 2 | 0 | ||||
| Superior Hypogastric Nerve Plexus Block With Bupivacaine After Robotic Resection of Endometriosis | Baylor College of Medicine | — |
Read-across commentary attached per trial. Phase ordering preserved within each group.
External analyst notes, journalism, and industry commentary cited with attribution.
"Sponsor guided" dates come from IR materials and earnings calls; hover for the cited source. "CT.gov proxy" dates fall back to the registry primary completion date — actual readouts typically follow by 3-6 months.
| — |
| — |
| — |
| — |
| — |
| Endometriosis and Pain Treatment by Intraoperative Administration of Low-dose Ketamine | Insel Gruppe AG, University Hospital Bern | — | Phase 4 | — | — | — | — | — |
| Comparison Between the Effects of Implantable Gestrinone and Oral Dienogest in the Treatment of Endometriosis | Bio Meds Pharmaceutica Ltda | — | Phase 4 | — | — | — | — | — |
| Endometriosis and Microvascular Dysfunction; Simvastatin and Duavee | Penn State University | — | Phase 4 | — | — | — | — | — |
| Assessing the Efficacy of Indocyanine Green for Ureter Identification During Robot-Assisted Surgery in Advanced-Stage Endometriosis | Baylor College of Medicine | — | Phase 4 | — | — | — | — | — |
| Endodontic Microsurgery | Mark Schachman | — | Phase 4 | — | — | — | — | — |
| Thromboxane Function in Women With Endometriosis | Penn State University | — | Phase 4 | — | — | — | — | — |
| Comparison of Elagolix and OCPs in Reducing Endometriosis Associated Pelvic Pain | Pak Emirates Military Hospital | — | Phase 4 | — | — | — | — | — |
| Estetrol/Drospirenone to Reduce the Average Size of Endometriomas | Andrew Zakhari | — | Phase 4 | — | — | — | — | — |
| Effect of a GnRH Analog on Hepatic Steatosis | Aristotle University Of Thessaloniki | — | Phase 4 | — | — | — | — | — |
| The Use of Low Dose Metronidazole to Decrease Postoperative Pain After Endometriosis Surgery | University of Louisville | — | Phase 4 | — | — | — | — | — |
| Ketamine in Central Sensitization | University Hospitals Cleveland Medical Center | — | Phase 4 | — | — | — | — | — |
| Effect GnRH Agonist Administration in Endometriosis Cyst Patients | Rumah Sakit Pusat Angkatan Darat Gatot Soebroto | — | Phase 3 | — | — | — | — | — |
| Study of the Safety and Contraceptive Efficacy of Relugolix Combination Therapy in Women With Uterine Fibroids or Endometriosis Who Are at Risk for Pregnancy | Sumitomo Pharma Switzerland GmbH | — | Phase 3 | — | — | — | — | — |
| Esketamine as Treatment for Chronic Pain Due to Endometriosis: a RCT Study | Reinier de Graaf Groep | — | Phase 3 | — | — | — | — | — |
| The Effect of Medical Management Following Excisional Surgery for Endometriosis: A Randomized Controlled Trial | Main Line Health | — | Phase 3 | — | — | — | — | — |
| The Role of Preoperative Immunonutrition on Morbidity and Immune Response After Cystectomy (INCyst Trial) | Centre Hospitalier Universitaire Vaudois | — | Phase 3 | — | — | — | — | — |
| Clinical Study to Compare Efficacy and Safety of Indinol Forto® 200 mg Capsules and Visanne 2 mg Tablets in Treatment of Endometriosis | Alcea | — | Phase 3 | — | — | — | — | — |
| Pre-IVF Treatment With a GnRH Antagonist in Women With endometriosis_temp | Yale University | — | Phase 3 | — | — | — | — | — |
| A Clinical Study of KLH-2109 in Patients With Endometriosis | Kissei Pharmaceutical Co., Ltd. | — | Phase 3 | — | — | — | — | — |
| Evaluate the Efficacy and Safety of HMI-115 in Women With Moderate to Severe Endometriosis-associated Pain | Hope Medicine (Nanjing) Co., Ltd | — | Phase 3 | — | — | — | — | — |
| Estradiol-mediated Inflammation and Central Sensitization in the Pathophysiology of Endometriosis-associated Pelvic Pain | University of Michigan | — | Phase 3 | — | — | — | — | — |
| Study Of Oral Elagolix Tablets In Combination With Combined Oral Contraceptive Capsules/Tablets To Assess Dysmenorrhea Response In Adult Female Participants With Endometriosis And Associated Moderate To Severe Pain | AbbVie | — | Phase 3 | — | — | — | — | — |
| A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or Endometriosis | Sumitomo Pharma Switzerland GmbH | — | Phase 3 | — | — | — | — | — |
| Benefit of GnRH Agonist Before Frozen Embryo Transfer in Patients With Endometriosis and/or Adenomyosis | Hopital Foch | — | PHASE2/PHASE3 | — | — | — | — | — |
| Proof of Concept Study to Eval MetriDx Lab-developed Test to Identify Endometriosis-specific Bio Markers | Hera Biotech, Inc. | — | Phase 2 | — | — | — | — | — |
| Anti-TNFα Therapy for Improving Pregnancy Rates in Endometriosis Patients With Failed ICSI | Benha University | — | Phase 2 | — | — | — | — | — |
| Evaluating the Impact of a Novel Cannabinoid Product for Endometriosis | Mclean Hospital | — | Phase 2 | — | — | — | — | — |
| Evaluation of Endometriosis With 18F-fluorofuranylnorprogesterone PET / MRI | University of North Carolina, Chapel Hill | — | Phase 2 | — | — | — | — | — |
| Glycemic Regulation as Endometriosis Adjunct Treatment | Boston Children's Hospital | — | Phase 2 | — | — | — | — | — |
| A Phase 2 Trial to Investigate Efficacy and Safety of Vipoglanstat in Women With Endometriosis | Gesynta Pharma AB | — | Phase 2 | — | — | — | — | — |
| A Phase IIa Clinical Study to Assess the Efficacy and Safety of GenSci048 in Patients With Moderate to Severe Endometriosis-Associated Pain | Changchun GeneScience Pharmaceutical Co., Ltd. | — | Phase 2 | — | — | — | — | — |